Novo Nordisk
Novo Nordisk is a Danish multinational pharmaceutical company that develops and manufactures insulin and diabetes delivery systems.
Business Model:
Revenue: $22.4B
Employees: 10,001-999,999
Industries / Tags:
Detailed Novo Nordisk Information
Geographic Data
Address: Novo Alle 1
City: Bagsvaerd
State: capital region
Zip: 2880
Country: DK
Financial Info
Stage:
post ipo equity
Raised Last:
$22M
Raised Total:$22M
Social
Metrics
237,932Website Global Rank
280,617Website Monthly Traffic
Twitter Followers
Description
Novo Nordisk is a Danish multinational pharmaceutical company that develops and manufactures insulin and diabetes delivery systems.
Contact Phone:
Contact Email:
Novo Nordisk went public on 5/8/1981 on the NYSE
Listed Exchange:
NYSE
IPO Date:
5/8/1981
Ticker Symbol:
NVO
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2022 | Ventus Therapeutics | Corporate Round | 70M |
| 3/2021 | Glooko | Series D | 0 |
| 1/2016 | IO Biotech | Series A | 11.8M |
| 9/2020 | Sundew | Seed Round | 0 |
| 9/2004 | Innate Pharma | Series C | 0 |
| 5/2023 | ElevateBio | Series D | 0 |
| 10/2007 | Xencor | Series E | 15M |
| 12/2015 | Beta Bionics | Series A | 5M |
| 9/2008 | Osprey Pharmaceuticals USA | Series A | 11M |
| 2/2022 | Beta Bionics | Series C | 0 |
| 4/2010 | Affimed | Series C | 0 |
| 2/2003 | TransTech Pharma | Venture Round | 0 |
| 2/2022 | Beta Bionics | Series C | 0 |
| 3/2021 | Glooko | Series D | 0 |
| 9/2020 | Sundew | Seed Round | 0 |
| 1/2016 | IO Biotech | Series A | 0 |
| 12/2015 | Beta Bionics | Series A | 0 |
| 4/2010 | Affimed | Series C | 0 |
| 9/2008 | Osprey Pharmaceuticals USA | Series A | 0 |
| 10/2007 | Xencor | Series E | 0 |
| 9/2004 | Innate Pharma | Series C | 0 |
| 2/2003 | TransTech Pharma | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2018 | Post-IPO Equity | $22M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 11/2021 | Dicerna Pharmaceuticals | |
| 11/2020 | Emisphere Technologies | |
| 6/2020 | Corvidia | |
| 8/2018 | Ziylo | |
| 8/2015 | MB2 | |
| 8/2015 | Calibrium | |
| 5/2013 | Xellia Pharmaceuticals | |
| 10/2003 | Aldaph SpA | |
| 1/1988 | ZymoGenetics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
